Glucocorticoids Antagonize RUNX2 During Osteoblast Differentiation in Cultures of ST2 Pluripotent Mesenchymal Cells

Glucocorticoid-Induced Osteoporosis and Osteonecrosis

(2012) Robert S. Weinstein   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism

(2012) Tara C. Brennan-Speranza et al.   JOURNAL OF CLINICAL INVESTIGATION

Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture

(2012) Karol Estrada et al.   NATURE GENETICS

The multiple facets of glucocorticoid action in rheumatoid arthritis

(2012) Ulrike Baschant et al.   Nature Reviews Rheumatology

Opposing Effects of Runx2 and Estradiol on Breast Cancer Cell Proliferation: In Vitro Identification of Reciprocally Regulated Gene Signature Related to Clinical Letrozole Responsiveness

(2011) N.-O. Chimge et al.   CLINICAL CANCER RESEARCH

Runx2 controls a feed-forward loop between androgen and prolactin-induced protein (PIP) in stimulating T47D cell proliferation

(2011) Sanjeev K. Baniwal et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells

(2011) S. K. Baniwal et al.   OSTEOPOROSIS INTERNATIONAL

Signaling networks in RUNX2-dependent bone development

(2010) Toshihisa Komori   JOURNAL OF CELLULAR BIOCHEMISTRY

Regulation of adult bone turnover by sex steroids

(2010) Baruch Frenkel et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Repression of Runx2 by Androgen Receptor (AR) in Osteoblasts and Prostate Cancer Cells: AR Binds Runx2 and Abrogates Its Recruitment to DNA

(2009) Sanjeev K. Baniwal et al.   MOLECULAR ENDOCRINOLOGY

Modulation of Runx2 Activity by Estrogen Receptor-α: Implications for Osteoporosis and Breast Cancer

(2008) Omar Khalid et al.   ENDOCRINOLOGY